BYSI BeyondSpring Inc
Company Analysis
Latest News
🔴 BeyondSpring is trading 6.45% down in pre-market amid broader risk-off trading
BeyondSpring is trading at $0.58 (-6.45%) amid broader risk-off trading. - No clear September 1, 2026 company-specific announcement, filing, earnings update,...
🔴 BeyondSpring is trading 8% down today with no clear company-specific catalyst identified
BeyondSpring is trading 8% down at $0.61 on August 31, 2026, with no clear company-specific catalyst identified. - No clear company-specific announcement,...
🔴 BeyondSpring is trading 6.25% down in after-hours trading with no clear catalyst identified
BeyondSpring is trading 6.25% down at $0.60 after closing August 27, 2026, at $0.64, with no clear company-specific catalyst identified. • The stock fell...
🔴 BeyondSpring is trading 10.14% down today
BeyondSpring is trading at $0.62, down 10.14% now, with no clear company-specific catalyst identified for August 27, 2026. - The decline is occurring while...
🔴 BeyondSpring is trading 7.26% down today
BeyondSpring is trading at $0.64 (-7.26%), with no clear catalyst identified for the decline. - No new company-specific announcement, filing, earnings...
🟢 BeyondSpring is trading 5.5% up today as XBI gains 2.06%
BeyondSpring is trading 5.5% up at $0.75, with biotech-sector momentum a stronger explanation for the move after no fresh company-specific announcement was...
🟢 BeyondSpring is trading 10% up in pre-market — catalyst remains unconfirmed
BeyondSpring is trading at $0.78 (+9.98%), with no fresh August 25 company announcement identified. - The latest company release, published August 15,...
🟢 BeyondSpring is trading 8.32% up today in pre-market following positive Moderna cancer-vaccine trial results
BeyondSpring is trading up +8.32% now at $0.78 after positive Moderna cancer-vaccine trial results lifted biotechnology sentiment. - No new company-specific...
🟢 BeyondSpring is trading 5.73% up today following positive Moderna cancer-vaccine trial results
BeyondSpring is trading 5.73% up at $0.76, with the move appearing mainly linked to stronger biotech-sector sentiment following positive Moderna cancer-vaccine...
🟢 BeyondSpring is trading 9.4% up in after-hours trading; catalyst unconfirmed
BeyondSpring is trading 9.4% up in after-hours trading at $0.79 after closing at $0.72 on August 19, 2026; the catalyst remains unconfirmed. - No new...
🟢 BeyondSpring is trading 6.29% up today amid a broad biotech-sector rally
BeyondSpring is trading 6.29% up now at $0.76 as biotechnology shares rally broadly on positive industry sentiment. - The sector’s strength appears to be the...
🟢 BeyondSpring is trading 5.4% up in pre-market driven by XBI's 2.27% gain
BeyondSpring is trading 5.42% up now at $0.76, mainly linked to stronger biotech sentiment, with no new company-specific announcement identified for August 19,...
🟢 BeyondSpring is trading 5.89% up in after-hours trading with no clear company-specific catalyst
BeyondSpring is trading 5.89% up at $0.76 in after-hours trading after closing at $0.72 on August 18, 2026, with no clear company-specific catalyst. - No...
🔴 BeyondSpring is trading 5.69% down today after cash fell to $6.5 million
BeyondSpring is trading at $0.67 (-5.69%) after its August 14, 2026, second-quarter update reported cash, equivalents, and short-term investments falling to...
🔴 BeyondSpring is trading 10.64% down today after Q2 report showed $6.5 million in liquidity
BeyondSpring is trading 10.64% down now at $0.75 as investors continue reacting to its August 14 second-quarter report and liquidity concerns. - The...
🔴 BeyondSpring is trading 8.59% down today after Q2 results flagged trial funding difficulties
BeyondSpring is trading at $0.77 (-8.59%) on August 17, 2026, following its August 14 second-quarter results, which raised concern about financing the planned...
BeyondSpring's Cash Dwindles as Losses Mount — Can a Pre-Revenue Biotech Survive Long Enough to Run Its Key Trial?
Shares of BeyondSpring Inc. slid to $0.78, extending a brutal week that has erased roughly 21% of the stock's value since August 10, after second-quarter...
🔴 BeyondSpring is trading 7% down in pre-market after Q2 report flagged financing needs for DUBLIN-4
BeyondSpring is trading 7% down in pre-market at $0.78 after its August 14, 2026 second-quarter report highlighted ongoing losses, limited cash, and financing...
BeyondSpring's second quarter 2026 net loss was $1.8 million as Phase 3 trial preparations continue
BeyondSpring reported a net loss from continuing operations of $1.8 million for the second quarter of 2026, as the company remains in a pre-revenue clinical...
🔴 BeyondSpring is trading 16.69% down today amid apparent profit-taking, no confirmed announcement
BeyondSpring is trading at $0.83, 16.69% down, apparently reflecting profit-taking and speculative volatility rather than a confirmed August 14 company...